ProShare Advisors LLC boosted its stake in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 15.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 103,544 shares of the electronics maker’s stock after buying an additional 13,475 shares during the period. ProShare Advisors LLC’s holdings in Dolby Laboratories were worth $6,650,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Ashton Thomas Private Wealth LLC acquired a new stake in Dolby Laboratories during the 3rd quarter worth about $615,000. JPMorgan Chase & Co. raised its holdings in Dolby Laboratories by 81.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 312,028 shares of the electronics maker’s stock worth $22,582,000 after buying an additional 139,900 shares during the period. Teacher Retirement System of Texas raised its holdings in Dolby Laboratories by 19.1% during the 4th quarter. Teacher Retirement System of Texas now owns 115,772 shares of the electronics maker’s stock worth $7,435,000 after buying an additional 18,579 shares during the period. Alps Advisors Inc. raised its holdings in Dolby Laboratories by 6.7% during the 3rd quarter. Alps Advisors Inc. now owns 281,532 shares of the electronics maker’s stock worth $20,374,000 after buying an additional 17,592 shares during the period. Finally, Clifford Capital Partners LLC raised its holdings in Dolby Laboratories by 15.2% during the 3rd quarter. Clifford Capital Partners LLC now owns 304,311 shares of the electronics maker’s stock worth $22,023,000 after buying an additional 40,252 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.
Analyst Ratings Changes
Several research firms have issued reports on DLB. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Rosenblatt Securities restated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a report on Friday, January 30th. Barrington Research restated an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, April 27th. Finally, Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $90.75.
Insider Buying and Selling at Dolby Laboratories
In other Dolby Laboratories news, CFO Robert J. Park sold 4,895 shares of Dolby Laboratories stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total transaction of $277,448.60. Following the transaction, the chief financial officer owned 81,490 shares of the company’s stock, valued at $4,618,853.20. The trade was a 5.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP John D. Couling sold 7,666 shares of Dolby Laboratories stock in a transaction dated Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total value of $441,178.30. Following the transaction, the senior vice president directly owned 118,353 shares in the company, valued at approximately $6,811,215.15. This trade represents a 6.08% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 20,249 shares of company stock valued at $1,157,434 in the last 90 days. 37.93% of the stock is currently owned by corporate insiders.
Dolby Laboratories Price Performance
NYSE:DLB opened at $54.69 on Friday. Dolby Laboratories has a fifty-two week low of $52.45 and a fifty-two week high of $77.00. The stock’s 50-day moving average is $60.04 and its two-hundred day moving average is $63.36. The stock has a market cap of $5.17 billion, a PE ratio of 21.62 and a beta of 0.86.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The company had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. During the same quarter in the previous year, the business posted $1.34 EPS. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, equities research analysts anticipate that Dolby Laboratories will post 3.22 earnings per share for the current year.
Dolby Laboratories Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend was Tuesday, May 12th. Dolby Laboratories’s payout ratio is 56.92%.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
